ARCHIVES

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Biostatisticians Write To Varmus Asking NCI To Investigate

July 23, 2010

CMS Dares Critics To Produce ESA Data; House Bill Seeks To Vacate Coverage Decision.

September 28, 2007

Pitt Criticizes NCI Stance On Repayment For Fraud Trials

September 9, 1994

In Brief: Tom Hall Names CMMI VP For Clinical Affairs; Rabson, Fauci Names to Institute Of Medicine

June 26, 1987

NCI to Implement More Transparent Formula For Calculating Cancer Center Support Grants

July 11, 2014

ORI Progress On Fisher Case Questioned; Panel Not Formed

March 3, 1995